Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MSCI Inc.MSCI · Entity 3075 | Chief Product Officer | April 24, 2026 | April 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MSCI Inc.
Report date April 24, 2026 · Filed April 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,548 |
Ending reported balance
After 2026-04-24 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-04-24 · Sale · Disposed 9,960 · Balance 23,588 F1: This transaction was executed in multiple trades at prices ranging from $592.00 to $592.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Row 2 · 2026-04-24 · Sale · Disposed 40 · Balance 23,548 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $592.00 to $592.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 24, 2026 Filed Apr 28, 2026 20:00 UTC | MSCI Inc. MSCI · Entity 3075 | SaleCommon Stock | 40 | $593.31 | $23,732.40 |
DisclosureSEC source: 0002101503-26-000009 · wk-form4_1777406449.xml · nonDerivative · entry 2 Munari Alvise J. · CIK 0002101503 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,548 Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 20:00 UTC | MSCI Inc. MSCI · Entity 3075 | SaleCommon Stock | 9,960 | $592.03 | $5,896,618.80 |
DisclosureSEC source: 0002101503-26-000009 · wk-form4_1777406449.xml · nonDerivative · entry 1 Munari Alvise J. · CIK 0002101503 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,588 F1 · price: This transaction was executed in multiple trades at prices ranging from $592.00 to $592.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request, to the SEC staff, the issuer or the security holders of the issuer full information regarding the number of shares and prices at which each transaction was effected. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:05 UTC | MSCI Inc. MSCI · Entity 3075 | Tax withholdingCommon Stock | 438 | $624.75 | $273,640.50 |
DisclosureSEC source: 0002101503-26-000006 · wk-form4_1770239108.xml · nonDerivative · entry 1 Munari Alvise J. · CIK 0002101503 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,548 F1 · shares: Represents shares reacquired by MSCI Inc. to satisfy tax withholding obligations in connection with the vesting and conversion to shares of 1,218 restricted stock units granted on February 2, 2023. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:01 UTC | MSCI Inc. MSCI · Entity 3075 | GrantCommon Stock | 3,158 | $0.00 | $0.00 |
DisclosureSEC source: 0002101503-26-000004 · wk-form4_1770152502.xml · nonDerivative · entry 1 Munari Alvise J. · CIK 0002101503 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,986 F1 · shares: Restricted stock units ("RSUs") that are expected to vest and convert to shares on the third anniversary of the grant date. The final number of shares issued upon vesting will be between 100% and 130% of the target number of RSUs based on achievement of a performance metric for the for the 2026 fiscal year (January 1, 2026 through December 31, 2026). Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 21:04 UTC | MSCI Inc. MSCI · Entity 3075 | GrantOption to purchase common stock · Derivative | 6,042 | $0.00 Strike: $554.52 | $0.00 |
DisclosureSEC source: 0002101503-26-000002 · wk-form4_1769634244.xml · derivative · entry 1 Munari Alvise J. · CIK 0002101503 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,042 Underlying: Common Stock · 6,042 shares Expires 2033-02-02 F1 · shares: Represents the number of performance stock options ("PSOs") to purchase common stock earned by the reporting person following the certification by the Compensation, Talent and Culture Committee on January 26, 2026 of the achievement of the performance condition applicable to the PSOs. The PSOs were granted on February 2, 2023 and vest on the third anniversary of the grant date, subject to continuous service through such date and satisfaction of the performance condition for the performance period from January 1, 2023 and ending on December 31, 2025. The performance condition for the PSOs was met with respect to 6,042 shares of common stock, and the PSOs are scheduled to vest on February 2, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.